South Wales, Dec. 26 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "HELUS PHARMA" on Dec. 10. The details about the trademark application no. UK00004308487 published in the journal no. 2025/051 (Dec. 19).
With Stobbs as representative, Cybin Corp. filed the trademark application for the below mentioned good(s)/service(s).
Class 1 : Active chemical ingredients for use in the manufacture of pharmaceuticals for treating mental health disorders; pharmaceutical active ingredients for clinical trials.
Class 5 : Pharmaceutical preparations for the treatment of neurological conditions and psychiatric conditions; pharmaceutical preparations for the treatment of depression and anxiety; pharmaceutical preparations for human use.
Class 42 : Pharmaceutical drug development services; pharmaceutical research and development services; consultancy relating to pharmaceutical research and development; conducting early evaluations in the field of new pharmaceuticals; conducting clinical trials for pharmaceutical products; scientific research for medical and healthcare purposes; product research and development in the field of major depressive disorders and other mental health disorders; providing medical and scientific research information in the field of clinical trials.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004308487
Disclaimer: Curated by HT Syndication.
